Plasma neuropeptide Y in patients with major depressive disorder

被引：6

作者：

Hashimoto, H ^{[1
]}

Onishi, H ^{[1
]}

Koide, S ^{[1
]}

Kai, T ^{[1
]}

Yamagami, S ^{[1
]}

机构：

[1] OSAKA CITY GEN HOSP, OSAKA, JAPAN

来源：

NEUROSCIENCE LETTERS | 1996年 / 216卷 / 01期

关键词：

neuropeptide Y; major depressive disorder; plasma; high performance liquid chromatography; radioimmunoassay analysis; neuropeptide; depression;

D O I：

暂无

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

It has been suggested that neuropeptide Y (NPY) is involved in the pathophysiology of depression. Plasma peptide-rich fraction from patients with major depressive disorder and control subjects was eluted with high performance liquid chromatography (HPLC), followed by radioimmunoassay of NPY. The screening patterns of the NPY-like immunoreactivity in 50 fractions eluted by HPLC from the plasma peptide-rich fraction were different between the two groups. The values of NPY in the 16 controls and the 14 patients were 427 +/- 38 and 310 +/- 27 fmol/ml plasma (P < 0.05), respectively. These results suggest that impaired metabolism of plasma NPY and the reduced plasma NPY in patients with major depressive disorder could be involved in the pathogenesis or pathophysiology of major depressive disorder.

引用

页码：57 / 60

页数：4

共 50 条

[31] Signatures of HIV and Major Depressive Disorder in the Plasma Microbiome
Taylor, Bryn C.
Sheikh Andalibi, Mohammadsobhan
Wandro, Stephen
Weldon, Kelly C.
Sepich-Poore, Gregory D.
Carpenter, Carolina S.
Fraraccio, Serena
Franklin, Donald
Iudicello, Jennifer E.
Letendre, Scott
Gianella, Sara
Grant, Igor
Ellis, Ronald J.
Heaton, Robert K.
Knight, Rob
Swafford, Austin D.
MICROORGANISMS, 2023, 11 (04)
[32] PLASMA GALANIN IS A BIOMARICER FOR SEVERITY OF MAJOR DEPRESSIVE DISORDER
Wang, Yong-Jun
Yang, Yu-Tao
Li, Hui
Liu, Po-Zi
Wang, Chuan-Yue
Xu, Zhi-Qing David
INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE, 2014, 48 (02): : 109 - 119
[33] Improving criteria for differentiating bipolar disorder and major depressive disorder in patients experiencing a major depressive episode
Bowden, C. L.
Angst, J.
Azorin, J. M.
Vieta, E.
Gamma, A.
Young, A.
BIPOLAR DISORDERS, 2012, 14 : 64 - 64
[34] A Neuropeptide Y Variant (rs16139) Associated with Major Depressive Disorder in Replicate Samples from Chinese Han Population
Wang, Yongjun
Yang, Yutao
Hui, Li
Tie, Changle
Li, Feng
Xu, Zhi-Qing David
Wang, Chuanyue
PLOS ONE, 2013, 8 (02):
[35] NEUROPEPTIDE Y GENE POLYMORPHISM AND PLASMA NEUROPEPTIDE Y LEVEL IN FEBRILE SEIZURE PATIENTS IN TAIWAN
Lin, Lung-Chang
Lin, Hung-Shun
Yang, Rei-Cheng
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2007, 23 (11): : 560 - 565
[36] The impact of migraine on patients with major depressive disorder
Hung, CI
Liu, CY
Juang, YY
Wang, SJ
HEADACHE, 2006, 46 (03): : 469 - 477
[37] IRRATIONAL BELIEFS OF PATIENTS WITH MAJOR DEPRESSIVE DISORDER
Mandic, V.
Perunicic, I.
Lukic, B.
Rakovic, I.
Marjanovic, S.
Tosevski, D. Lecic
EUROPEAN PSYCHIATRY, 2010, 25
[38] Psychiatric comorbidities in patients with major depressive disorder
Thaipisuttikul, Papan
Ittasakul, Pichai
Waleeprakhon, Punjaporn
Wisajun, Pattarabhorn
Jullagate, Sudawan
NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2014, 10 : 2097 - 2103
[39] Impaired intuition in patients with major depressive disorder
Remmers, Carina
Topolinski, Sascha
Dietrich, Detlef E.
Michalak, Johannes
BRITISH JOURNAL OF CLINICAL PSYCHOLOGY, 2015, 54 (02) : 200 - 213
[40] Neurocognitive Dysfunction in Patients of Major Depressive Disorder
Shah, Bhavik
Kataria, Lakhan
Tanna, Kajal
INDIAN JOURNAL OF PSYCHIATRY, 2016, 58 (05) : S44 - S44

← 1 2 3 4 5 →